3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
54
Stomach Neoplasms
42
Carcinoma, Non-Small-Cell Lung
31
Colorectal Neoplasms
21
Esophageal Squamous Cell Carcinoma
15
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Rectal Neoplasms
10
Esophageal Neoplasms
9
Pancreatic Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Small Cell Lung Carcinoma
5
Neoplasms
5
Liver Neoplasms
5
Cholangiocarcinoma
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Recurrence
4
Neoplasm Metastasis
4
Carcinoma, Renal Cell
4
Lymphoma, Extranodal NK-T-Cell
3
Colorectal Cancer Metastatic
3
Colonic Neoplasms
3
Carcinoma
3
Breast Neoplasms
3
Turcot syndrome
2
Thyroid Neoplasms
2
Spinocerebellar Degenerations
2
Sarcoma
2
Nonsquamous Non-Small Cell Lung Cancer
2
Interventions
lenvatinib
3
Gemcitabine
3
tislelizumab
2
durvalumab
2
Cisplatin
2
toripalimab
1
titanium silicide
1
theasinensin A
1
surufatinib
1
sitravatinib
1
sintilimab
1
regorafenib
1
pembrolizumab
1
S 1 (combination)
1
Nivolumab
1
Folfox protocol
1
Fluorouracil
1
Cryosurgery
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Biliary Tract Cancer
×
sintilimab
×
Clear all
NCT05781074
2023-03-24
CASTLE-08
Fudan University
Phase 2
Unknown
25 enrolled